Asmaa S A Yassen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Chronic Myeloid Leukemia

Signaling Pathway

Crystal Structure

Breast Cancer Cells

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Ranza Elrayess, Mohamed Saleh Elgawish, Mohamed S Nafie, Nagat Ghareb, Asmaa S A Yassen
2-Phenylquinazolin-4(3H)-one scaffold as newly designed, synthesized VEGFR-2 allosteric inhibitors with potent cytotoxicity through apoptosis. Archiv der Pharmazie (2023)
Safaa M Kishk, Enas E Eltamany, Mohamed S Nafie, Roaa M Khinkar, Rawan H Hareeri, Sameh S Elhady, Asmaa S A Yassen
Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells. Molecules (Basel, Switzerland) 27 (19) (2022)
Safaa M Kishk, Rania M Kishk, Asmaa S A Yassen, Mohamed S Nafie, Nader A Nemr, Gamal Elmasry, Salim Al-Rejaie, Claire Simons
Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies. Molecules (Basel, Switzerland) 25 (21) (2020)
Ranza Elrayess, Yasmine M Abdel Aziz, Mohamed Saleh Elgawish, Marwa Elewa, Asmaa S A Yassen, Sameh S Elhady, Hosam A Elshihawy, Mohamed M Said
Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line. Pharmaceuticals (Basel, Switzerland) 14 (1) (2020)
Ranza Elrayess, Mohamed Saleh Elgawish, Marwa Elewa, Mohamed S Nafie, Sameh S Elhady, Asmaa S A Yassen
Synthesis, 3D-QSAR, and Molecular Modeling Studies of Triazole Bearing Compounds as a Promising Scaffold for Cyclooxygenase-2 Inhibition. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)